digital virtual currency, Block

Judging from the market performance, the average growth rate of 41 key sector stocks since September 18 is close to 56%, far outperforming the performance of the broader market in the same period. Among them, two stocks of Xinxiangwei and SMIC doubled. Xinxiangwei's main business focuses on the research, development, design and sales of display chips, and is committed to providing complete display chip system solutions.[The time is ripe for Shanghai stocks to become monsters in batches! 】In the secondary market, the concept stocks of M&A and restructuring rose strongly, and the restructuring index rose nearly 63% since September 24th.

Judging from the market performance, the average growth rate of 41 key sector stocks since September 18 is close to 56%, far outperforming the performance of the broader market in the same period. Among them, two stocks of Xinxiangwei and SMIC doubled. Xinxiangwei's main business focuses on the research, development, design and sales of display chips, and is committed to providing complete display chip system solutions.Many stocks have doubled.After-hours big profits are related to mergers and acquisitions, restructuring, Shanghai state-owned shares have these.

Zhongwei company is a company engaged in the research, development, production and sales of high-end semiconductor equipment and pan-semiconductor equipment. Great Wall Securities said that the company's etching, thin film deposition and MOCVD equipment have reached the international advanced level.The stagflation stocks mainly include Haohaishengke, Shanghai Laishi and Weir. Among them, Haohai Shengke increased by less than 10%. The company is a scientific and technological innovative enterprise that applies biomedical materials technology and genetic engineering technology to research, develop, produce and sell medical devices and drugs. It is committed to providing innovative medical products for the market through technological innovation and transformation, integration of domestic and foreign resources and large-scale production, and gradually realizing the import substitution of related medical products, thus becoming a leading enterprise in the field of biomedical materials.